| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 3236-71-3 | 雙酚芴 | 4,4'-(9-Fluorenylidene)diphenol; 9,9-Bis(4-hydroxyphenyl)fluorene |  | C25H18O2 | 詳情 | 供應(yīng)商 |
| 116989-76-5 | Acetic acid,2-[[5-(6H-indolo[2,3-b]quinoxalin-6-ylmethyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio]-; Aceticacid, [[5-(6H-indolo[2,3-b]quinoxalin-6-ylmethyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio]-(9CI); 6H-Indolo[2,3-b]quinoxaline, acetic acid deriv. |  | C25H18N6O2S | 詳情 | 供應(yīng)商 | |
| 93413-07-1 | Quinazolino[3,2-d][1,4]benzodiazepine-6,9(5H,7H)-dione,7-(1H-indol-3-ylmethyl)-, (7S)-; Quinazolino[3,2-d][1,4]benzodiazepine-6,9(5H,7H)-dione,7-(1H-indol-3-ylmethyl)-, (S)-; Asperlicin D |  | C25H18N4O2 | 詳情 | 供應(yīng)商 | |
| 93413-06-0 | Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione,6,7-dihydro-7-(1H-indol-3-ylmethyl)-, (7S)-; Quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione,6,7-dihydro-7-(1H-indol-3-ylmethyl)-, (S)-; (-)-Asperlicin C; Asperlicin C |  | C25H18N4O2 | 詳情 | 供應(yīng)商 | |
| 127662-45-7 | 4H-Imidazol-4-one,3-[4-(4-chlorophenoxy)phenyl]-3,5-dihydro-5-(1H-indol-2-ylmethylene)-2-methyl- |  | C25H18ClN3O2 | 詳情 | 供應(yīng)商 | |
| 127662-47-9 | 4H-Imidazol-4-one,3-[4-(4-fluorophenoxy)phenyl]-3,5-dihydro-5-(1H-indol-2-ylmethylene)-2-methyl- |  | C25H18FN3O2 | 詳情 | 供應(yīng)商 | |
| 74165-76-7 | 9,10-Anthracenedione,1-amino-2-methyl-4-(2-naphthalenylamino)-; 1-amino-2-methyl-4-(naphthalen-2-ylamino)anthracene-9,10-dione |  | C25H18N2O2 | 詳情 | 供應(yīng)商 | |
| 544417-40-5 | 卡帕諾生; 卡帕諾生 | CAPADENOSON; CAPADENOSON; 2-Amino-6-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyethoxy)phenyl]-3,5-pyridinedicarbonitrile; BAY 68-4986 |  | C25H18ClN5O2S2 | 詳情 | 供應(yīng)商 |